Carfilzomib Consolidation Therapy After Autologous Stem Cell Transplantation (ASCT) for Mantle Cell Lymphoma (MCL), T-cell Lymphoma (TCL), and Diffuse Large B-Cell Lymphoma (DLBCL)
Clinical trial NCT01926665 · COMPLETED
Trial details
- NCT number
- NCT01926665
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-17
- Primary completion
- 2017-09-17
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.